You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

CORPORATE

Letter to patient associations and scientific organizations

Communication from Paolo Marcucci, Chairman & CEO of Kedrion

read more 

EVENTS

Kedrion keeps Hemophilia therapy debate flowing in Latin America

A recent CLAHT Congress symposium restates current and future role of replacement therapy

read more 
  1. CORPORATE - 25-03-2020

    Letter to patient associations and scientific organizations

    Communication from Paolo Marcucci, Chairman & CEO of Kedrion

    read more 
  2. EVENTS - 18-11-2019

    Kedrion keeps Hemophilia therapy debate flowing in Latin America

    A recent CLAHT Congress symposium restates current and future role of replacement therapy

    read more 
  3. EVENTS - 09-11-2017

    Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

    This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

    read more 

Pages

For more information please contact: pressoffice@kedrion.com